Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novartis
Pharma
Ono-Deciphera, Novartis-PeptiDream, WuXi Bio—Fierce Pharma Asia
Ono will buy Deciphera for $2.4 billion. Novartis invests further in radiotherapy with two deals. WuXi Biologics has withdrawn from the BIO 2024.
Angus Liu
May 3, 2024 7:20am
Novartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia
Apr 26, 2024 5:45am
Day One pressures Novartis with FDA nod for novel RAF inhibitor
Apr 23, 2024 10:13pm
Novartis gears up for key expansions of 3 cancer drugs
Apr 23, 2024 3:37pm
Novartis reviews ties to China amid US biosecurity crackdown
Apr 23, 2024 11:07am
Novartis nominates ex-BMS chief Caforio as its next chair
Apr 23, 2024 2:44am